Spring of 2023 Edelman – Gardner Research Update
In 2023 our annual $50,000 donation was awarded to Pilot funding through the Wilmot Cancer Institute Team Science Pilot Award Program, for the project entitled “The Development of Extracellular Vesicles as a Biomarker for Antitumor Immune Responses.” The researchers associated with this project are: James McGrath and Scott Gerber.
In Layman’s terms: Pancreatic cancer is a devastating disease often diagnosed at an advanced stage. WCI’s research team has figured out how detect small particles unique to pancreatic tumor cells, enabling the potential to identify pancreatic cancer in its early stages, when it’s more amenable to treatment. This detection technology can also be used to monitor the effectiveness of treatment against the cancer. This breakthrough could significantly improve early detection and monitoring of pancreatic cancer, leading to better patient outcomes.
